Actively Recruiting
Study to Evaluate Safety and Effectiveness of SpectraCure P18 System and Verteporfin Injection for Treating Recurrent Prostate Cancer in Men
Led by SpectraCure AB · Updated on 2026-05-01
66
Participants Needed
4
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Prostate cancer is one of the most common cancers affecting men, and many men experience a return of the cancer after initial treatment. This research aims to study the safety and effectiveness of a treatment using the SpectraCure P18 System combined with the drug verteporfin for injection VFI in men with recurrent prostate cancer. The study focuses on finding appropriate dose levels and understanding how well this treatment works for patients who have already received radiation therapy and have limited treatment options due to recurrence. Participants will receive interstitial photodynamic therapy, where light is delivered to the tumor through optical fibers using the SpectraCure P18 System, along with the drug verteporfin as a photosensitizer. This dose titration study will help determine the safe and effective levels of both the light and drug doses. The treatment is given after confirming local recurrence of prostate cancer following previous radiation therapy. During the study, participants will be monitored closely with laboratory tests, biopsies, and imaging to assess safety and treatment effects. Researchers will track side effects related to the treatment within 4 weeks and evaluate cancer presence through biopsies at 6 months. Additional follow-ups at 12 months will assess tumor status, biochemical markers, and possible spread of disease. The total participation time varies, with close monitoring of treatment safety and effectiveness over the year following therapy.
CONDITIONS
Brief Title
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Research Team
J
Johannes Swartling
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here